Aradhana Kar, MD
Internal Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 8 carriers
- Offices
- 3
Offices
3 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
28 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kar’s office at (650) 967-8841 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A90567 · Current
Licensed to practise in California · since 2005 · expires 2027-01-31 · Utkal University, S. C. B. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
19 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Testing for PharyngitisAs Medicare defines this measure | 10% | 20 |
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 86% | 50 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 96%That's most of the people this applied to. | 1,155 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 64%That's more than half. | 423 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 2%That's few of the people this applied to. Better on this measure. | 171 |
| Breast cancer screeningEligible women who got a mammogram | 76%That's most of the people this applied to. | 466 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 23%That's few of the people this applied to. | 505 |
| Checked for fall riskOlder patients screened for fall risk | 71%That's more than half. | 510 |
See the other 11 measures
| Chlamydia Screening for WomenAs Medicare defines this measure | 39% | 23 |
| Colon cancer screeningEligible adults who got a colon cancer test | 57%That's more than half. | 909 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 61%That's more than half. | 1,153 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 18%That's few of the people this applied to. | 189 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 25%That's less than half. Better on this measure. | 189 |
| HIV screeningEligible patients who were screened for HIV | 8%That's few of the people this applied to. | 923 |
| Medications listed in the chartVisits where the current medication list was documented | 65%That's more than half. | 3,926 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 590 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 2,746 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 60%That's more than half. | 602 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 32%That's less than half. | 1,377 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$159,480
Medicare paid this office $159,480 for 319 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 272 | $72,259 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 234 | $37,542 | $160 |
| Short return visit (20+ min) | 135 | $14,207 | $79 |
| Long return visit (40+ min) | 48 | $7,584 | $140 |
| Annual alcohol misuse screening, 5 to 15 minutes | 262 | $6,496 | $25 |
See all 15 services
| Return visit (30+ min) | 272 | $72,259 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 234 | $37,542 | $160 |
| Short return visit (20+ min) | 135 | $14,207 | $79 |
| Long return visit (40+ min) | 48 | $7,584 | $140 |
| Annual alcohol misuse screening, 5 to 15 minutes | 262 | $6,496 | $25 |
| Annual depression screening, 5 to 15 minutes | 213 | $5,281 | $25 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $3,029 | $202 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 13 | $2,630 | $202 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 118 | $2,556 | $15 |
| Advance care planning, first 30 minutes | 26 | $1,888 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 37 | $516 | $13 |
| Injection of drug or substance under skin or into muscle | 12 | $423 | $11 |
| Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | 14 | $370 | $26 |
| Administration of vaccine | 14 | $284 | $20 |
| Urinalysis, manual test | 22 | $89 | $3 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
319 Original Medicare patients in 2024. Average age 75 · Women 63% · Health risk score 0.87. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 74% · Coronary heart disease 27% · Diabetes 22% · Cancer 16% · Chronic kidney disease 14% · Depression 12% · Heart failure 11% · Atrial fibrillation 11% · COPD 8% · Dementia 6% · Stroke 5%.
The office billed $595,049, Medicare allowed $201,799 and paid $159,480; for 5,060 services of 48 kinds; $942 of it was for drugs given in the office and $158,538 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 319 | 5,060 | 75 | 0.87 | $595,049 | $159,480 |
| 2023 | 321 | 3,876 | 75 | 0.76 | $574,001 | $147,780 |
| 2022 | 334 | 2,484 | 75 | 0.80 | $414,034 | $98,462 |
| 2021 | 349 | 1,355 | 76 | 0.88 | $349,038 | $89,025 |
| 2020 | 227 | 1,125 | 75 | 0.89 | $126,802 | $53,988 |
| 2019 | 217 | 975 | 75 | 0.85 | $129,063 | $56,044 |
| 2018 | 229 | 1,052 | 74 | 0.80 | $137,304 | $62,109 |
| 2017 | 177 | 762 | 74 | 0.82 | $100,794 | $46,316 |
| 2016 | 172 | 594 | 74 | 0.83 | $86,075 | $38,417 |
| 2015 | 95 | 279 | 72 | 0.86 | $42,115 | $17,880 |
| 2014 | 95 | 283 | 74 | 0.80 | $41,539 | $17,696 |
| 2013 | 91 | 259 | 72 | 0.78 | $37,517 | $15,734 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 282 | $69,338 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 224 | $34,922 | $156 |
| Long return visit (40+ min) | 66 | $11,389 | $163 |
| Short return visit (20+ min) | 89 | $8,843 | $75 |
| Advance care planning, first 30 minutes | 101 | $7,683 | $75 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 20 | $3,949 | $197 |
| Annual depression screening, 5 to 15 minutes | 111 | $2,614 | $24 |
| Annual alcohol misuse screening, 5 to 15 minutes | 89 | $2,096 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 41 | $652 | $13 |
| Urinalysis, manual test | 25 | $147 | $3 |
2022: 6 services
| Return visit (30+ min) | 317 | $77,856 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $12,516 | $158 |
| Short return visit (20+ min) | 32 | $2,658 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $477 | $13 |
| Injection of drug or substance under skin or into muscle | 12 | $328 | $14 |
| Urinalysis, manual test | 23 | $103 | $3 |
2021: 8 services
| Return visit (30+ min) | 314 | $65,368 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $8,301 | $163 |
| Short return visit (20+ min) | 51 | $4,343 | $71 |
| Long return visit (40+ min) | 21 | $3,853 | $168 |
| Short return visit | 11 | $692 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $416 | $15 |
| Removal of impacted ear wax by washing | 11 | $270 | $17 |
| Urinalysis, manual test | 19 | $77 | $3 |
2020: 10 services
| Return visit (30+ min) | 185 | $27,776 | $84 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 47 | $8,883 | $34 |
| Short return visit (20+ min) | 71 | $5,448 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,312 | $136 |
| Influenza vaccine split virus, preservative free | 24 | $1,247 | $50 |
| Administration of influenza virus vaccine | 26 | $564 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $408 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $346 | $22 |
| Administration of pneumococcal vaccine | 11 | $228 | $21 |
| Urinalysis, manual test | 14 | $48 | $3 |
2019: 13 services
| Return visit (30+ min) | 168 | $28,420 | $86 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 46 | $6,828 | $33 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,302 | $133 |
| Short return visit (20+ min) | 62 | $4,118 | $53 |
| Pneumococcal vaccine, 13-valent | 11 | $2,301 | $209 |
| Long return visit (40+ min) | 12 | $1,692 | $130 |
| Influenza vaccine split virus, preservative free | 14 | $720 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $473 | $15 |
| Administration of influenza virus vaccine | 17 | $390 | $21 |
| Injection of drug or substance under skin or into muscle | 14 | $375 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $305 | $20 |
| Administration of pneumococcal vaccine | 12 | $246 | $21 |
| Urinalysis, manual test | 12 | $44 | $3 |
2018: 11 services
| Return visit (30+ min) | 155 | $25,019 | $87 |
| Short return visit (20+ min) | 104 | $9,489 | $63 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 43 | $7,966 | $35 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,134 | $133 |
| Pneumococcal vaccine, 13-valent | 11 | $2,199 | $200 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $2,051 | $71 |
| Long return visit (40+ min) | 13 | $1,685 | $130 |
| Influenza vaccine split virus, preservative free | 34 | $1,513 | $44 |
| X-ray of chest, 2 views | 30 | $915 | $25 |
| Administration of influenza virus vaccine | 35 | $901 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $430 | $15 |
2017: 11 services
| Return visit (30+ min) | 125 | $18,430 | $85 |
| Short return visit (20+ min) | 64 | $5,212 | $59 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 36 | $4,356 | $36 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,553 | $132 |
| Pneumococcal vaccine, 13-valent | 12 | $2,231 | $186 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $2,195 | $78 |
| Influenza vaccine split virus, preservative free | 36 | $1,585 | $44 |
| Administration of influenza virus vaccine | 36 | $1,161 | $32 |
| X-ray of chest, 2 views, front and side | 19 | $476 | $24 |
| Administration of pneumococcal vaccine | 12 | $356 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $344 | $14 |
2016: 10 services
| Return visit (30+ min) | 101 | $14,074 | $84 |
| Short return visit (20+ min) | 68 | $5,170 | $55 |
| Pneumococcal vaccine, 13-valent | 27 | $4,768 | $177 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,138 | $131 |
| New patient visit (45+ min) | 18 | $1,530 | $85 |
| Influenza vaccine split virus, preservative free | 37 | $1,480 | $40 |
| Administration of influenza virus vaccine | 41 | $1,236 | $30 |
| Administration of pneumococcal vaccine | 32 | $943 | $29 |
| X-ray of chest, 2 views, front and side | 14 | $416 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $389 | $14 |
2015: 5 services
| Return visit (30+ min) | 66 | $9,940 | $86 |
| Short return visit (20+ min) | 32 | $2,672 | $59 |
| Influenza vaccine split virus, preservative free | 14 | $477 | $34 |
| Administration of influenza virus vaccine | 13 | $385 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $218 | $16 |
2014: 5 services
| Return visit (30+ min) | 72 | $10,009 | $85 |
| Short return visit (20+ min) | 34 | $2,470 | $59 |
| Influenza vaccine split virus, preservative free | 12 | $388 | $32 |
| Administration of influenza virus vaccine | 13 | $382 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $197 | $15 |
2013: 5 services
| Return visit (30+ min) | 53 | $7,481 | $84 |
| Short return visit (20+ min) | 31 | $1,932 | $57 |
| Administration of influenza virus vaccine | 18 | $533 | $30 |
| Influenza vaccine split virus, preservative free | 16 | $496 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $253 | $17 |
Drugs they prescribed that Part D paid
$419,020
Pharmacies billed $419,020 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (139 of 5,391) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
4,761 generic and 602 brand-name prescriptions · $419,020 in drug cost · 252 antibiotic prescriptions to 143 people · 35 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 64 | $52,993 | $828 |
| Ozempic | 27 | $32,802 | $1,215 |
| Jardiance | 23 | $27,828 | $1,210 |
| Spiriva Respimat | 25 | $24,238 | $970 |
| Januvia | 15 | $21,057 | $1,404 |
See all 109 drugs
| Eliquis | 64 | $52,993 | $828 |
| Ozempic | 27 | $32,802 | $1,215 |
| Jardiance | 23 | $27,828 | $1,210 |
| Spiriva Respimat | 25 | $24,238 | $970 |
| Januvia | 15 | $21,057 | $1,404 |
| Trelegy Ellipta | 26 | $15,506 | $596 |
| Repatha Sureclick | 13 | $8,156 | $627 |
| Dulera | 13 | $4,666 | $359 |
| Wixela Inhub | 28 | $3,768 | $135 |
| Lansoprazole | 12 | $3,602 | $300 |
| Synthroid | 37 | $2,553 | $69 |
| Albuterol Sulfate Hfa | 63 | $2,439 | $39 |
| Levothyroxine | 251 | $2,419 | $10 |
| Butalbital-Acetaminophen-Caffe | 12 | $2,256 | $188 |
| Atorvastatin | 240 | $2,016 | $8 |
| Nebivolol | 31 | $2,007 | $65 |
| Fenofibrate | 12 | $1,949 | $162 |
| Pravastatin | 128 | $1,917 | $15 |
| Gabapentin | 102 | $1,900 | $19 |
| Hydrocodone-Acetaminophen | 96 | $1,824 | $19 |
| Amlodipine Besylate | 303 | $1,757 | $6 |
| Losartan | 146 | $1,736 | $12 |
| Duloxetine | 52 | $1,476 | $28 |
| Estradiol | 27 | $1,465 | $54 |
| Rosuvastatin | 113 | $1,396 | $12 |
| Montelukast | 133 | $1,380 | $10 |
| Metoprolol | 114 | $1,290 | $11 |
| Pantoprazole | 105 | $1,142 | $11 |
| Ezetimibe | 37 | $1,107 | $30 |
| Valsartan | 54 | $1,039 | $19 |
| Ondansetron Odt | 31 | $1,025 | $33 |
| Celecoxib | 24 | $1,020 | $43 |
| Escitalopram | 58 | $1,008 | $17 |
| Lisinopril | 129 | $952 | $7 |
| Metformin | 130 | $949 | $7 |
| Butorphanol | 12 | $942 | $79 |
| Omeprazole | 64 | $887 | $14 |
| Zolpidem | 138 | $832 | $6 |
| Azelastine | 32 | $805 | $25 |
| Nano 2nd Gen Pen Needle | 13 | $800 | $62 |
| Bupropion Xl | 38 | $796 | $21 |
| Sertraline | 47 | $740 | $16 |
| Alendronate | 49 | $736 | $15 |
| Fenofibrate | 12 | $651 | $54 |
| Clopidogrel | 36 | $624 | $17 |
| Venlafaxine Hcl Er | 24 | $602 | $25 |
| Valacyclovir | 25 | $596 | $24 |
| Diltiazem 24hr Er (Cd) | 27 | $586 | $22 |
| Finasteride | 21 | $566 | $27 |
| Potassium Chloride | 35 | $564 | $16 |
| Estradiol (Twice Weekly) | 17 | $545 | $32 |
| Tamsulosin | 48 | $530 | $11 |
| Triamterene-Hydrochlorothiazid | 36 | $527 | $15 |
| Irbesartan-Hydrochlorothiazide | 12 | $508 | $42 |
| Nitrofurantoin Mono-Macro | 36 | $489 | $14 |
| Metformin Hcl Er | 59 | $484 | $8 |
| Diltiazem | 12 | $457 | $38 |
| Metronidazole | 12 | $451 | $38 |
| Olmesartan Medoxomil | 14 | $400 | $29 |
| Clotrimazole-Betamethasone | 21 | $393 | $19 |
| Losartan-Hydrochlorothiazide | 28 | $373 | $13 |
| Trazodone | 83 | $372 | $4 |
| Allopurinol | 34 | $342 | $10 |
| Famotidine | 22 | $340 | $15 |
| Benazepril | 34 | $333 | $10 |
| Oxybutynin Chloride Er | 16 | $304 | $19 |
| Hydrochlorothiazide | 69 | $291 | $4 |
| Acetaminophen-Codeine | 14 | $285 | $20 |
| Cephalexin | 48 | $283 | $6 |
| Atenolol | 31 | $261 | $8 |
| Doxycycline Monohydrate | 26 | $249 | $10 |
| Ketoconazole | 13 | $233 | $18 |
| Isosorbide Mononitrate Er | 12 | $230 | $19 |
| Quetiapine | 22 | $228 | $10 |
| Baclofen | 32 | $223 | $7 |
| Ramipril | 15 | $217 | $14 |
| Simvastatin | 46 | $208 | $5 |
| Buspirone | 21 | $203 | $10 |
| Doxazosin Mesylate | 11 | $202 | $18 |
| Hydrocortisone | 27 | $190 | $7 |
| Azithromycin | 59 | $174 | $3 |
| Paroxetine | 13 | $171 | $13 |
| Furosemide | 20 | $168 | $8 |
| Metoprolol | 51 | $160 | $3 |
| Hydroxyzine | 15 | $158 | $11 |
| Tramadol | 29 | $142 | $5 |
| Irbesartan | 20 | $137 | $7 |
| Triamcinolone Acetonide | 11 | $130 | $12 |
| Mupirocin | 17 | $125 | $7 |
| Tizanidine | 18 | $119 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $115 | $10 |
| Carvedilol | 13 | $113 | $9 |
| Glimepiride | 12 | $106 | $9 |
| Lovastatin | 12 | $106 | $9 |
| Alprazolam | 30 | $101 | $3 |
| Cyclobenzaprine | 14 | $97 | $7 |
| Acyclovir | 12 | $85 | $7 |
| Diazepam | 31 | $84 | $3 |
| Donepezil | 13 | $83 | $6 |
| Naproxen | 12 | $68 | $6 |
| Ciprofloxacin | 11 | $62 | $6 |
| Clonazepam | 16 | $47 | $3 |
| Prednisone | 20 | $43 | $2 |
| Lorazepam | 38 | $39 | $1 |
| Ibuprofen | 18 | $39 | $2 |
| Clindamycin | 13 | $33 | $3 |
| Amoxicillin | 18 | $26 | $1 |
| Citalopram Hbr | 13 | $15 | $1 |
| Paxlovid | 20 | $0 | $0 |
Year by year
| 2024 | 5,391 | 409 | 3% (139) | 11% | $419,020 |
| 2023 | 5,400 | 426 | 2% (124) | 12% | $436,274 |
| 2022 | 5,699 | 460 | 3% (185) | 11% | $407,816 |
| 2021 | 3,729 | 483 | 4% (144) | 12% | $263,414 |
| 2020 | 1,537 | 218 | 4% (54) | 13% | $110,112 |
| 2019 | 1,222 | 211 | 4% (50) | None | $98,789 |
| 2018 | 1,249 | 214 | 3% (38) | None | $107,951 |
| 2017 | 1,169 | 169 | 4% (41) | None | $80,931 |
| 2016 | 1,116 | 160 | 7% (78) | 16% | $62,934 |
| 2015 | 991 | 115 | 6% (63) | None | $48,968 |
| 2014 | 906 | 114 | 4% (36) | None | $53,670 |
| 2013 | 681 | 87 | 3% (19) | None | $36,076 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 104 drugs
| Eliquis | 85 | $61,112 | $719 |
| Jardiance | 27 | $33,498 | $1,241 |
| Rybelsus | 16 | $16,466 | $1,029 |
| Edarbi | 11 | $6,837 | $622 |
| Trelegy Ellipta | 11 | $6,364 | $579 |
| Levothyroxine | 268 | $4,407 | $16 |
| Nebivolol | 28 | $4,098 | $146 |
| Butorphanol | 13 | $3,869 | $298 |
| Albuterol Sulfate Hfa | 57 | $3,499 | $61 |
| Rosuvastatin | 124 | $3,398 | $27 |
| Atorvastatin | 263 | $2,896 | $11 |
| Losartan | 167 | $2,804 | $17 |
| Butalbital-Acetaminophen-Caffe | 13 | $2,754 | $212 |
| Hydrocodone-Acetaminophen | 95 | $2,468 | $26 |
| Pravastatin | 129 | $2,355 | $18 |
| Amlodipine Besylate | 291 | $2,179 | $7 |
| Synthroid | 29 | $2,116 | $73 |
| Gabapentin | 100 | $2,061 | $21 |
| Montelukast | 123 | $1,964 | $16 |
| Pantoprazole | 89 | $1,816 | $20 |
| Metoprolol | 117 | $1,796 | $15 |
| Duloxetine | 36 | $1,770 | $49 |
| Ezetimibe | 28 | $1,578 | $56 |
| Valsartan | 40 | $1,521 | $38 |
| Lansoprazole | 11 | $1,443 | $131 |
| Estradiol | 18 | $1,269 | $71 |
| Omeprazole | 71 | $1,196 | $17 |
| Lisinopril | 128 | $1,123 | $9 |
| Valacyclovir | 25 | $1,116 | $45 |
| Escitalopram | 56 | $1,110 | $20 |
| Estradiol (Twice Weekly) | 21 | $1,055 | $50 |
| Tamsulosin | 63 | $1,048 | $17 |
| Trazodone | 99 | $1,026 | $10 |
| Metformin | 114 | $1,013 | $9 |
| Clotrimazole-Betamethasone | 19 | $971 | $51 |
| Azelastine | 29 | $971 | $33 |
| Clopidogrel | 43 | $934 | $22 |
| Alendronate | 49 | $919 | $19 |
| Bupropion | 14 | $869 | $62 |
| Celecoxib | 16 | $866 | $54 |
| Omega-3 Acid Ethyl Esters | 15 | $864 | $58 |
| Zolpidem | 137 | $844 | $6 |
| Diltiazem | 12 | $830 | $69 |
| Sertraline | 54 | $816 | $15 |
| Nitrofurantoin Mono-Macro | 56 | $787 | $14 |
| Benazepril | 47 | $742 | $16 |
| Baclofen | 17 | $704 | $41 |
| Potassium Chloride | 32 | $656 | $21 |
| Metformin Hcl Er | 31 | $652 | $21 |
| Buspirone | 24 | $623 | $26 |
| Venlafaxine | 13 | $608 | $47 |
| Triamterene-Hydrochlorothiazid | 42 | $601 | $14 |
| Famotidine | 26 | $585 | $22 |
| Allopurinol | 39 | $584 | $15 |
| Cefdinir | 14 | $506 | $36 |
| Quetiapine Fumarate Er | 11 | $487 | $44 |
| Ketoconazole | 12 | $459 | $38 |
| Hydrochlorothiazide | 75 | $451 | $6 |
| Simvastatin | 53 | $427 | $8 |
| Diazepam | 47 | $420 | $9 |
| Ramipril | 20 | $414 | $21 |
| Atenolol | 35 | $411 | $12 |
| Venlafaxine Hcl Er | 21 | $406 | $19 |
| Irbesartan | 16 | $382 | $24 |
| Losartan-Hydrochlorothiazide | 19 | $376 | $20 |
| Desonide | 12 | $375 | $31 |
| Quetiapine | 47 | $366 | $8 |
| Bisoprolol | 11 | $363 | $33 |
| Doxazosin Mesylate | 13 | $360 | $28 |
| Furosemide | 25 | $349 | $14 |
| Ondansetron Odt | 21 | $332 | $16 |
| Azithromycin | 57 | $330 | $6 |
| Bupropion Xl | 32 | $330 | $10 |
| Paxlovid (Eua) | 30 | $319 | $11 |
| Metoprolol | 42 | $312 | $7 |
| Finasteride | 20 | $308 | $15 |
| Irbesartan-Hydrochlorothiazide | 16 | $281 | $18 |
| Cephalexin | 40 | $276 | $7 |
| Citalopram Hbr | 20 | $265 | $13 |
| Acyclovir | 11 | $252 | $23 |
| Eszopiclone | 12 | $244 | $20 |
| Donepezil | 13 | $236 | $18 |
| Amitriptyline | 22 | $227 | $10 |
| Alprazolam | 37 | $223 | $6 |
| Carvedilol | 16 | $206 | $13 |
| Diclofenac | 12 | $205 | $17 |
| Fluoxetine | 12 | $199 | $17 |
| Paroxetine | 11 | $195 | $18 |
| Ibandronate | 12 | $191 | $16 |
| Hydrocortisone | 20 | $182 | $9 |
| Glipizide | 14 | $167 | $12 |
| Clonazepam | 38 | $165 | $4 |
| Tramadol | 24 | $152 | $6 |
| Lovastatin | 14 | $148 | $11 |
| Lorazepam | 50 | $134 | $3 |
| Lagevrio (Eua) | 12 | $126 | $11 |
| Mupirocin | 12 | $117 | $10 |
| Mirtazapine | 11 | $103 | $9 |
| Prednisone | 27 | $97 | $4 |
| Triamcinolone Acetonide | 12 | $96 | $8 |
| Ciprofloxacin | 16 | $87 | $5 |
| Tizanidine | 17 | $82 | $5 |
| Temazepam | 16 | $56 | $3 |
| Amoxicillin | 11 | $48 | $4 |
2022: 109 drugs
| Eliquis | 50 | $34,230 | $685 |
| Xarelto | 12 | $17,689 | $1,474 |
| Januvia | 13 | $16,236 | $1,249 |
| Tradjenta | 11 | $12,337 | $1,122 |
| Lantus Solostar | 12 | $11,059 | $922 |
| Symbicort | 18 | $7,374 | $410 |
| Rosuvastatin | 108 | $6,016 | $56 |
| Estring | 11 | $5,703 | $518 |
| Levothyroxine | 295 | $5,553 | $19 |
| Aripiprazole | 13 | $4,474 | $344 |
| Memantine Hcl Er | 12 | $4,101 | $342 |
| Butorphanol | 12 | $3,516 | $293 |
| Nebivolol | 30 | $3,441 | $115 |
| Synthroid | 36 | $3,091 | $86 |
| Hydrocodone-Acetaminophen | 121 | $2,913 | $24 |
| Atorvastatin | 267 | $2,810 | $11 |
| Celecoxib | 34 | $2,593 | $76 |
| Duloxetine | 41 | $2,564 | $63 |
| Amlodipine Besylate | 310 | $2,528 | $8 |
| Albuterol Sulfate Hfa | 29 | $2,054 | $71 |
| Pravastatin | 115 | $1,995 | $17 |
| Losartan | 127 | $1,899 | $15 |
| Gabapentin | 88 | $1,816 | $21 |
| Montelukast | 103 | $1,752 | $17 |
| Ventolin Hfa | 20 | $1,662 | $83 |
| Metoprolol | 112 | $1,640 | $15 |
| Tolterodine | 14 | $1,451 | $104 |
| Tamsulosin | 74 | $1,416 | $19 |
| Omeprazole | 78 | $1,265 | $16 |
| Lisinopril | 157 | $1,262 | $8 |
| Nano 2nd Gen Pen Needle | 12 | $1,255 | $105 |
| Estradiol | 22 | $1,240 | $56 |
| Pantoprazole | 98 | $1,224 | $12 |
| Irbesartan | 20 | $1,207 | $60 |
| Eszopiclone | 15 | $1,189 | $79 |
| Ezetimibe | 23 | $1,184 | $51 |
| Valacyclovir | 27 | $1,158 | $43 |
| Potassium Chloride | 33 | $1,151 | $35 |
| Alendronate | 53 | $1,090 | $21 |
| Estradiol (Twice Weekly) | 17 | $1,057 | $62 |
| Pregabalin | 13 | $1,027 | $79 |
| Valsartan | 23 | $981 | $43 |
| Trazodone | 99 | $919 | $9 |
| Clopidogrel | 30 | $891 | $30 |
| Venlafaxine Hcl Er | 33 | $890 | $27 |
| Metformin | 146 | $890 | $6 |
| Sertraline | 62 | $881 | $14 |
| Venlafaxine | 14 | $811 | $58 |
| Zolpidem | 132 | $810 | $6 |
| Oxybutynin Chloride Er | 13 | $798 | $61 |
| Zolpidem Tartrate Er | 12 | $780 | $65 |
| Azelastine | 20 | $780 | $39 |
| Benazepril | 59 | $770 | $13 |
| Escitalopram | 39 | $733 | $19 |
| Oxycodone-Acetaminophen | 17 | $712 | $42 |
| Diltiazem 24hr Er (Cd) | 13 | $711 | $55 |
| Triamterene-Hydrochlorothiazid | 57 | $659 | $12 |
| Nitrofurantoin Mono-Macro | 32 | $651 | $20 |
| Baclofen | 19 | $650 | $34 |
| Clotrimazole-Betamethasone | 18 | $635 | $35 |
| Hydrochlorothiazide | 102 | $625 | $6 |
| Quetiapine | 38 | $615 | $16 |
| Fenofibrate | 12 | $585 | $49 |
| Allopurinol | 40 | $578 | $14 |
| Losartan-Hydrochlorothiazide | 30 | $570 | $19 |
| Simvastatin | 77 | $562 | $7 |
| Quetiapine Fumarate Er | 13 | $543 | $42 |
| Buspirone | 26 | $526 | $20 |
| Bupropion | 14 | $519 | $37 |
| Amitriptyline | 37 | $495 | $13 |
| Hydralazine | 21 | $489 | $23 |
| Metformin Hcl Er | 19 | $484 | $25 |
| Azithromycin | 62 | $473 | $8 |
| Ondansetron Odt | 20 | $451 | $23 |
| Atenolol | 47 | $431 | $9 |
| Bupropion Xl | 22 | $429 | $19 |
| Diazepam | 56 | $425 | $8 |
| Irbesartan-Hydrochlorothiazide | 15 | $414 | $28 |
| Finasteride | 26 | $410 | $16 |
| Doxazosin Mesylate | 20 | $401 | $20 |
| Fluoxetine | 50 | $390 | $8 |
| Mometasone Furoate | 11 | $389 | $35 |
| Famotidine | 30 | $368 | $12 |
| Lorazepam | 75 | $346 | $5 |
| Donepezil | 17 | $336 | $20 |
| Citalopram Hbr | 21 | $326 | $16 |
| Olmesartan Medoxomil | 16 | $316 | $20 |
| Clonazepam | 47 | $289 | $6 |
| Cephalexin | 37 | $282 | $8 |
| Alprazolam | 27 | $266 | $10 |
| Diclofenac | 11 | $263 | $24 |
| Ramipril | 21 | $262 | $12 |
| Metoprolol | 56 | $253 | $5 |
| Paxlovid (Eua) | 26 | $252 | $10 |
| Carvedilol | 20 | $250 | $13 |
| Ibuprofen | 22 | $222 | $10 |
| Lagevrio (Eua) | 22 | $215 | $10 |
| Triamcinolone Acetonide | 12 | $182 | $15 |
| Lisinopril-Hydrochlorothiazide | 13 | $175 | $13 |
| Tramadol | 40 | $174 | $4 |
| Furosemide | 17 | $147 | $9 |
| Hydrocortisone | 12 | $135 | $11 |
| Prednisone | 21 | $112 | $5 |
| Glipizide | 12 | $108 | $9 |
| Ciprofloxacin | 19 | $107 | $6 |
| Temazepam | 23 | $107 | $5 |
| Lovastatin | 17 | $71 | $4 |
| Tizanidine | 12 | $61 | $5 |
| Amoxicillin | 19 | $59 | $3 |
2021: 80 drugs
| Eliquis | 25 | $17,171 | $687 |
| Edarbi | 16 | $8,972 | $561 |
| Bystolic | 21 | $6,999 | $333 |
| Symbicort | 13 | $5,110 | $393 |
| Levothyroxine | 192 | $4,067 | $21 |
| Wixela Inhub | 15 | $3,798 | $253 |
| Synthroid | 33 | $2,482 | $75 |
| Hydrocodone-Acetaminophen | 86 | $2,352 | $27 |
| Rosuvastatin | 47 | $1,949 | $41 |
| Albuterol Sulfate Hfa | 27 | $1,793 | $66 |
| Atorvastatin | 157 | $1,788 | $11 |
| Pregabalin | 11 | $1,674 | $152 |
| Losartan | 117 | $1,446 | $12 |
| Amlodipine Besylate | 198 | $1,404 | $7 |
| Metoprolol | 71 | $1,277 | $18 |
| Ezetimibe | 24 | $1,187 | $49 |
| Pravastatin | 84 | $1,178 | $14 |
| Celecoxib | 15 | $1,145 | $76 |
| Montelukast | 71 | $1,122 | $16 |
| Potassium Chloride | 22 | $1,100 | $50 |
| Nano 2nd Gen Pen Needle | 12 | $1,021 | $85 |
| Lisinopril | 131 | $1,000 | $8 |
| Gabapentin | 53 | $969 | $18 |
| Pantoprazole | 64 | $915 | $14 |
| Omeprazole | 50 | $864 | $17 |
| Oxycodone-Acetaminophen | 14 | $802 | $57 |
| Tamsulosin | 48 | $762 | $16 |
| Escitalopram | 34 | $747 | $22 |
| Amitriptyline | 19 | $730 | $38 |
| Metformin | 96 | $725 | $8 |
| Baclofen | 22 | $719 | $33 |
| Zolpidem | 75 | $694 | $9 |
| Alendronate | 38 | $678 | $18 |
| Duloxetine | 19 | $611 | $32 |
| Simvastatin | 57 | $582 | $10 |
| Metoprolol | 64 | $579 | $9 |
| Valacyclovir | 13 | $514 | $40 |
| Valsartan | 12 | $491 | $41 |
| Losartan-Hydrochlorothiazide | 13 | $489 | $38 |
| Triamterene-Hydrochlorothiazid | 32 | $477 | $15 |
| Benazepril | 28 | $476 | $17 |
| Lorazepam | 48 | $463 | $10 |
| Nitrofurantoin Mono-Macro | 20 | $458 | $23 |
| Metformin Hcl Er | 25 | $442 | $18 |
| Hydrochlorothiazide | 65 | $440 | $7 |
| Irbesartan | 11 | $392 | $36 |
| Sertraline | 29 | $374 | $13 |
| Venlafaxine Hcl Er | 21 | $366 | $17 |
| Famotidine | 16 | $359 | $22 |
| Clopidogrel | 20 | $354 | $18 |
| Allopurinol | 21 | $346 | $16 |
| Trazodone | 46 | $309 | $7 |
| Doxazosin Mesylate | 16 | $284 | $18 |
| Finasteride | 16 | $284 | $18 |
| Alprazolam | 26 | $275 | $11 |
| Irbesartan-Hydrochlorothiazide | 13 | $273 | $21 |
| Cephalexin | 49 | $266 | $5 |
| Acyclovir | 11 | $253 | $23 |
| Fluticasone Propionate | 15 | $248 | $17 |
| Lovastatin | 21 | $214 | $10 |
| Citalopram Hbr | 16 | $196 | $12 |
| Quetiapine | 17 | $192 | $11 |
| Azithromycin | 32 | $191 | $6 |
| Ibuprofen | 25 | $189 | $8 |
| Atenolol | 22 | $171 | $8 |
| Carvedilol | 15 | $171 | $11 |
| Mupirocin | 11 | $158 | $14 |
| Diazepam | 23 | $156 | $7 |
| Ramipril | 13 | $151 | $12 |
| Buspirone | 21 | $147 | $7 |
| Fluoxetine | 15 | $130 | $9 |
| Furosemide | 20 | $124 | $6 |
| Cyclobenzaprine | 13 | $122 | $9 |
| Prednisone | 24 | $112 | $5 |
| Tramadol | 26 | $105 | $4 |
| Clonazepam | 30 | $97 | $3 |
| Glipizide | 12 | $94 | $8 |
| Temazepam | 13 | $66 | $5 |
| Amoxicillin | 16 | $57 | $4 |
| Lisinopril-Hydrochlorothiazide | 11 | $48 | $4 |
2020: 38 drugs
| Levothyroxine | 112 | $2,643 | $24 |
| Wixela Inhub | 16 | $2,119 | $132 |
| Ezetimibe | 25 | $1,002 | $40 |
| Atorvastatin | 58 | $975 | $17 |
| Montelukast | 49 | $747 | $15 |
| Losartan | 41 | $629 | $15 |
| Olmesartan Medoxomil | 16 | $599 | $37 |
| Synthroid | 14 | $529 | $38 |
| Lisinopril | 62 | $508 | $8 |
| Hydrocodone-Acetaminophen | 21 | $497 | $24 |
| Amlodipine Besylate | 66 | $459 | $7 |
| Pravastatin | 20 | $439 | $22 |
| Metoprolol | 18 | $337 | $19 |
| Metformin | 30 | $312 | $10 |
| Triamcinolone Acetonide | 17 | $303 | $18 |
| Metoprolol | 27 | $295 | $11 |
| Nitrofurantoin Mono-Macro | 14 | $281 | $20 |
| Alendronate | 25 | $277 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $264 | $22 |
| Hydrochlorothiazide | 39 | $260 | $7 |
| Gabapentin | 19 | $256 | $13 |
| Azithromycin | 41 | $253 | $6 |
| Pantoprazole | 19 | $240 | $13 |
| Clotrimazole-Betamethasone | 12 | $240 | $20 |
| Lovastatin | 11 | $215 | $20 |
| Escitalopram | 11 | $200 | $18 |
| Cyclobenzaprine | 15 | $197 | $13 |
| Trazodone | 19 | $197 | $10 |
| Cephalexin | 27 | $175 | $6 |
| Simvastatin | 19 | $164 | $9 |
| Alprazolam | 30 | $155 | $5 |
| Quetiapine | 14 | $122 | $9 |
| Prednisone | 18 | $111 | $6 |
| Amoxicillin | 14 | $92 | $7 |
| Zolpidem | 20 | $82 | $4 |
| Tramadol | 21 | $75 | $4 |
| Buspirone | 11 | $63 | $6 |
| Clonazepam | 17 | $48 | $3 |
2019: 33 drugs
| Bystolic | 21 | $8,640 | $411 |
| Tradjenta | 14 | $6,419 | $459 |
| Edarbi | 20 | $5,495 | $275 |
| Levothyroxine | 74 | $1,619 | $22 |
| Wixela Inhub | 11 | $1,244 | $113 |
| Atorvastatin | 46 | $814 | $18 |
| Hydrocodone-Acetaminophen | 23 | $718 | $31 |
| Montelukast | 25 | $460 | $18 |
| Metoprolol | 22 | $460 | $21 |
| Synthroid | 12 | $435 | $36 |
| Diclofenac | 12 | $379 | $32 |
| Lisinopril | 53 | $365 | $7 |
| Losartan | 30 | $360 | $12 |
| Amlodipine Besylate | 44 | $357 | $8 |
| Zolpidem Tartrate Er | 11 | $318 | $29 |
| Pravastatin | 19 | $314 | $17 |
| Nitrofurantoin Mono-Macro | 16 | $308 | $19 |
| Azithromycin | 38 | $300 | $8 |
| Simvastatin | 22 | $292 | $13 |
| Metformin Hcl Er | 14 | $272 | $19 |
| Metformin | 18 | $224 | $12 |
| Cephalexin | 26 | $178 | $7 |
| Zolpidem | 23 | $177 | $8 |
| Metoprolol | 13 | $174 | $13 |
| Trazodone | 19 | $166 | $9 |
| Alprazolam | 29 | $148 | $5 |
| Hydrochlorothiazide | 23 | $126 | $5 |
| Acetaminophen-Codeine | 13 | $81 | $6 |
| Diazepam | 11 | $61 | $6 |
| Tramadol | 12 | $53 | $4 |
| Prednisone | 13 | $48 | $4 |
| Amoxicillin | 12 | $46 | $4 |
| Clonazepam | 16 | $39 | $2 |
2018: 32 drugs
| Edarbi | 25 | $5,319 | $213 |
| Advair Diskus | 14 | $4,618 | $330 |
| Bystolic | 14 | $4,421 | $316 |
| Incruse Ellipta | 12 | $3,847 | $321 |
| Uloric | 11 | $3,487 | $317 |
| Arnuity Ellipta | 13 | $2,904 | $223 |
| Levothyroxine | 62 | $1,312 | $21 |
| Esomeprazole Magnesium | 13 | $1,067 | $82 |
| Metoprolol | 34 | $984 | $29 |
| Celecoxib | 14 | $770 | $55 |
| Metformin | 29 | $661 | $23 |
| Atorvastatin | 28 | $600 | $21 |
| Montelukast | 34 | $509 | $15 |
| Azithromycin | 69 | $509 | $7 |
| Simvastatin | 19 | $492 | $26 |
| Hydrocodone-Acetaminophen | 24 | $467 | $19 |
| Synthroid | 12 | $428 | $36 |
| Losartan | 44 | $395 | $9 |
| Pravastatin | 19 | $388 | $20 |
| Amlodipine Besylate | 51 | $335 | $7 |
| Lisinopril | 45 | $283 | $6 |
| Allopurinol | 12 | $212 | $18 |
| Cephalexin | 27 | $203 | $8 |
| Metoprolol | 16 | $170 | $11 |
| Zolpidem | 20 | $162 | $8 |
| Trazodone | 30 | $152 | $5 |
| Alprazolam | 22 | $140 | $6 |
| Amoxicillin | 16 | $94 | $6 |
| Prednisone | 20 | $86 | $4 |
| Hydrochlorothiazide | 12 | $58 | $5 |
| Clonazepam | 16 | $53 | $3 |
| Diazepam | 11 | $40 | $4 |
2017: 31 drugs
| Advair Diskus | 21 | $7,329 | $349 |
| Qvar | 12 | $2,570 | $214 |
| Celecoxib | 11 | $1,489 | $135 |
| Metoprolol | 36 | $1,242 | $35 |
| Levothyroxine | 57 | $1,235 | $22 |
| Atorvastatin | 39 | $617 | $16 |
| Rosuvastatin | 14 | $611 | $44 |
| Losartan | 54 | $400 | $7 |
| Montelukast | 21 | $398 | $19 |
| Potassium Chloride | 16 | $353 | $22 |
| Pravastatin | 14 | $276 | $20 |
| Tamsulosin | 13 | $272 | $21 |
| Azithromycin | 38 | $252 | $7 |
| Allopurinol | 17 | $227 | $13 |
| Metformin | 22 | $227 | $10 |
| Hydrocodone-Acetaminophen | 20 | $221 | $11 |
| Amlodipine Besylate | 53 | $194 | $4 |
| Lisinopril | 42 | $172 | $4 |
| Cephalexin | 23 | $163 | $7 |
| Gabapentin | 17 | $156 | $9 |
| Alprazolam | 21 | $150 | $7 |
| Fluoxetine | 15 | $137 | $9 |
| Trazodone | 25 | $133 | $5 |
| Prednisone | 12 | $108 | $9 |
| Zolpidem | 12 | $105 | $9 |
| Hydrochlorothiazide | 22 | $81 | $4 |
| Furosemide | 17 | $67 | $4 |
| Ciprofloxacin | 11 | $50 | $5 |
| Amoxicillin | 12 | $48 | $4 |
| Escitalopram | 12 | $46 | $4 |
| Clonazepam | 11 | $26 | $2 |
2016: 35 drugs
| Bystolic | 11 | $2,158 | $196 |
| Celecoxib | 16 | $2,112 | $132 |
| Myrbetriq | 12 | $1,807 | $151 |
| Pilocarpine | 12 | $1,600 | $133 |
| Levothyroxine | 60 | $1,039 | $17 |
| Oxycodone-Acetaminophen | 15 | $882 | $59 |
| Metoprolol | 27 | $780 | $29 |
| Atorvastatin | 37 | $708 | $19 |
| Hydrocodone-Acetaminophen | 29 | $619 | $21 |
| Pravastatin | 26 | $392 | $15 |
| Azithromycin | 43 | $379 | $9 |
| Losartan | 34 | $373 | $11 |
| Metformin | 37 | $293 | $8 |
| Tamsulosin | 15 | $270 | $18 |
| Montelukast | 16 | $258 | $16 |
| Lisinopril | 64 | $250 | $4 |
| Triamterene-Hydrochlorothiazid | 11 | $233 | $21 |
| Gabapentin | 19 | $198 | $10 |
| Bupropion Hcl Sr | 11 | $188 | $17 |
| Simvastatin | 21 | $180 | $9 |
| Omeprazole | 19 | $146 | $8 |
| Acetaminophen-Codeine | 18 | $139 | $8 |
| Zolpidem | 14 | $131 | $9 |
| Amlodipine Besylate | 45 | $129 | $3 |
| Allopurinol | 15 | $127 | $8 |
| Alendronate | 13 | $118 | $9 |
| Metoprolol | 12 | $114 | $9 |
| Cephalexin | 23 | $114 | $5 |
| Trazodone | 19 | $112 | $6 |
| Alprazolam | 15 | $104 | $7 |
| Amoxicillin | 13 | $83 | $6 |
| Terazosin | 11 | $62 | $6 |
| Escitalopram | 13 | $62 | $5 |
| Citalopram Hbr | 12 | $55 | $5 |
| Prednisone | 11 | $50 | $5 |
2015: 29 drugs
| Celecoxib | 15 | $2,966 | $198 |
| Duloxetine | 14 | $1,595 | $114 |
| Levothyroxine | 64 | $1,159 | $18 |
| Montelukast | 11 | $731 | $66 |
| Hydrocodone-Acetaminophen | 34 | $617 | $18 |
| Voltaren | 12 | $556 | $46 |
| Gabapentin | 35 | $476 | $14 |
| Bupropion Hcl Sr | 15 | $429 | $29 |
| Metoprolol | 26 | $414 | $16 |
| Atorvastatin | 28 | $318 | $11 |
| Pravastatin | 16 | $309 | $19 |
| Lisinopril | 53 | $277 | $5 |
| Amlodipine Besylate | 48 | $258 | $5 |
| Losartan | 29 | $235 | $8 |
| Levofloxacin | 12 | $233 | $19 |
| Metformin | 39 | $228 | $6 |
| Tamsulosin | 12 | $194 | $16 |
| Simvastatin | 15 | $162 | $11 |
| Fluoxetine | 14 | $159 | $11 |
| Azithromycin | 20 | $128 | $6 |
| Alendronate | 15 | $117 | $8 |
| Zolpidem | 13 | $112 | $9 |
| Omeprazole | 15 | $99 | $7 |
| Terazosin | 18 | $98 | $5 |
| Trazodone | 13 | $94 | $7 |
| Donepezil | 13 | $65 | $5 |
| Allopurinol | 11 | $58 | $5 |
| Tramadol | 11 | $41 | $4 |
| Furosemide | 12 | $33 | $3 |
2014: 30 drugs
| Xarelto | 13 | $3,632 | $279 |
| Januvia | 11 | $3,288 | $299 |
| Nasonex | 13 | $3,160 | $243 |
| Diovan | 14 | $2,432 | $174 |
| Levothyroxine | 52 | $696 | $13 |
| Atorvastatin | 39 | $606 | $16 |
| Montelukast | 12 | $567 | $47 |
| Hydrocodone-Acetaminophen | 19 | $397 | $21 |
| Pravastatin | 19 | $345 | $18 |
| Amlodipine Besylate | 42 | $265 | $6 |
| Metformin | 45 | $262 | $6 |
| Metoprolol | 12 | $243 | $20 |
| Losartan | 22 | $225 | $10 |
| Bupropion Hcl Sr | 11 | $189 | $17 |
| Gabapentin | 19 | $181 | $10 |
| Diltiazem 24hr Er | 11 | $170 | $15 |
| Lovastatin | 11 | $166 | $15 |
| Tamsulosin | 11 | $142 | $13 |
| Metformin Hcl Er | 16 | $141 | $9 |
| Alendronate | 14 | $139 | $10 |
| Azithromycin | 14 | $128 | $9 |
| Lisinopril | 32 | $128 | $4 |
| Cephalexin | 18 | $101 | $6 |
| Metoprolol | 24 | $100 | $4 |
| Hydrochlorothiazide | 19 | $94 | $5 |
| Zolpidem | 16 | $91 | $6 |
| Terazosin | 17 | $84 | $5 |
| Ciprofloxacin | 12 | $68 | $6 |
| Fluoxetine | 11 | $65 | $6 |
| Furosemide | 19 | $46 | $2 |
2013: 17 drugs
| Celebrex | 11 | $3,478 | $316 |
| Nasonex | 13 | $2,090 | $161 |
| Diovan | 13 | $1,987 | $153 |
| Dexilant | 12 | $1,975 | $165 |
| Atorvastatin | 38 | $887 | $23 |
| Montelukast | 11 | $688 | $63 |
| Levocetirizine Dihydrochloride | 12 | $324 | $27 |
| Pravastatin | 17 | $285 | $17 |
| Lisinopril | 33 | $266 | $8 |
| Levothyroxine | 31 | $257 | $8 |
| Amlodipine Besylate | 30 | $179 | $6 |
| Gabapentin | 14 | $167 | $12 |
| Simvastatin | 16 | $165 | $10 |
| Metformin | 24 | $160 | $7 |
| Metoprolol | 30 | $154 | $5 |
| Levofloxacin | 11 | $112 | $10 |
| Metformin Hcl Er | 13 | $103 | $8 |
Money from drug and device companies
$1,371 in 2025
| 2025 | 12 | 72 | None | $1,371 |
| 2024 | 12 | 114 | None | $2,192 |
| 2023 | 11 | 79 | None | $1,073 |
| 2022 | 8 | 47 | None | $524 |
| 2021 | 8 | 47 | None | $551 |
| 2020 | 12 | 26 | None | $509 |
| 2019 | 25 | 108 | None | $1,944 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri | $205 | 10 payments
|
| Lilly USA | Mounjaro | $195 | 10 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $180 | 8 payments
|
| Abbvie | Ubrelvy | $179 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $167 | 11 payments
|
| Novo Nordisk | Wegovy | $144 | 7 payments
|
See all 69 published payments
| Lilly USA | Meals · 2025-12-21 | Jardiance | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-17 | None | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-11 | Breztri | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-04 | Breztri | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-20 | Jardiance | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-13 | Breztri | $20 |
| Abbvie | Meals · 2025-11-05 | Ubrelvy | $17 |
| Exact Sciences | Meals · 2025-11-03 | Cologuard Collection Kit | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-27 | Jardiance | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-23 | Breztri | $21 |
| Novo Nordisk | Meals · 2025-10-22 | Rybelsus | $9 |
| Abbvie | Meals · 2025-10-14 | Ubrelvy | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-29 | Jardiance | $25 |
| Novo Nordisk | Meals · 2025-09-25 | Wegovy | $35 |
| GlaxoSmithKline | Meals · 2025-09-25 | Trelegy Ellipta | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-23 | None | $16 |
| Edwards Lifesciences | Meals · 2025-09-23 | Sapien 3 Ultra Resilia | $33 |
| Abbvie | Meals · 2025-09-20 | Qulipta | $22 |
| Pfizer | Meals · 2025-09-18 | Nurtec Odt | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Breztri | $20 |
| GlaxoSmithKline | Meals · 2025-09-10 | Arexvy | $30 |
| Lilly USA | Meals · 2025-09-03 | Mounjaro | $25 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-03 | Caplyta | $16 |
| Novo Nordisk | Meals · 2025-08-27 | Rybelsus | $15 |
| Lilly USA | Meals · 2025-08-06 | Kisunla | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-31 | Jardiance | $18 |
| Lilly USA | Meals · 2025-07-30 | Jardiance | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-23 | Caplyta | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-17 | None | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-04 | Caplyta | $19 |
| Lilly USA | Meals · 2025-06-24 | Kisunla | $20 |
| IBSA Pharma | Meals · 2025-06-11 | Tirosint | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-04 | Jardiance | $12 |
| GlaxoSmithKline | Meals · 2025-05-21 | Trelegy Ellipta | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-14 | Jardiance | $13 |
| Lilly USA | Meals · 2025-05-06 | Jardiance | $16 |
| Exact Sciences | Meals · 2025-04-30 | Cologuard Collection Kit | $21 |
| GlaxoSmithKline | Meals · 2025-04-29 | Arexvy | $29 |
| Pfizer | Meals · 2025-04-29 | Nurtec Odt | $29 |
| Abbvie | Meals · 2025-04-26 | Ubrelvy | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-25 | Airsupra | $37 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-24 | None | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-18 | None | $20 |
| GlaxoSmithKline | Meals · 2025-04-17 | Trelegy Ellipta | $34 |
| Lilly USA | Meals · 2025-04-15 | Kisunla | $23 |
| Novo Nordisk | Meals · 2025-04-14 | Wegovy | $28 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-07 | Jardiance | $11 |
| Abbvie | Meals · 2025-04-04 | Ubrelvy | $19 |
| Novo Nordisk | Meals · 2025-04-02 | Ozempic | $19 |
| GlaxoSmithKline | Meals · 2025-03-19 | Trelegy Ellipta | $9 |
| GlaxoSmithKline | Meals · 2025-03-17 | Trelegy Ellipta | $12 |
| Lilly USA | Meals · 2025-03-14 | Mounjaro | $28 |
| Abbvie | Meals · 2025-03-07 | Qulipta | $13 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-06 | Jardiance | $11 |
| Novo Nordisk | Meals · 2025-02-27 | Wegovy | $14 |
| Abbvie | Meals · 2025-02-22 | Ubrelvy | $10 |
| Pfizer | Meals · 2025-02-14 | Paxlovid | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-10 | Jardiance | $11 |
| Lilly USA | Meals · 2025-02-07 | Jardiance | $12 |
| Novo Nordisk | Meals · 2025-02-05 | Rybelsus | $24 |
| Amgen | Meals · 2025-02-05 | Otezla | $14 |
| Pfizer | Meals · 2025-02-04 | Nurtec Odt | $24 |
| Abbvie | Meals · 2025-01-28 | Ubrelvy | $23 |
| GlaxoSmithKline | Meals · 2025-01-24 | Trelegy Ellipta | $32 |
| Exact Sciences | Meals · 2025-01-22 | Cologuard Collection Kit | $25 |
| Abbvie | Meals · 2025-01-15 | Ubrelvy | $13 |
| Lilly USA | Meals · 2025-01-14 | Mounjaro | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-13 | Jardiance | $11 |
| Abbvie | Meals · 2025-01-11 | Qulipta | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,192
| Abbvie | Qulipta | $772 | 34 payments
|
| GlaxoSmithKline | Arexvy | $271 | 15 payments
|
| Novo Nordisk | Ozempic | $247 | 14 payments
|
| Amgen | Otezla | $222 | 17 payments
|
| Lilly USA | Jardiance | $207 | 8 payments
|
| Pfizer | Nurtec Odt | $196 | 10 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $136 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $53 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $27 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $25 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $13 | 1 payment
|
2023: $1,073
| Abbvie | Vraylar | $480 | 44 payments
|
| GlaxoSmithKline | Arexvy | $162 | 10 payments
|
| Pfizer | Nurtec Odt | $145 | 10 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $72 | 4 payments
|
| Exact Sciences | Cologuard Collection Kit | $63 | 3 payments
|
| Lilly USA | Mounjaro | $37 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $36 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $27 | 1 payment
|
| Novo Nordisk | Rybelsus | $21 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $16 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $14 | 1 payment
|
2022: $524
| Abbvie | Ubrelvy | $379 | 36 payments
|
| Kowa Pharmaceuticals America | Livalo | $28 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $28 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $26 | 2 payments
|
| Organon | Nexplanon | $22 | 3 payments
|
| Novo Nordisk | Rybelsus | $17 | 1 payment
|
| Lilly USA | None | $12 | 1 payment
|
| Amgen | Otezla | $11 | 1 payment
|
2021: $551
| Novo Nordisk | Ozempic | $143 | 11 payments
|
| AbbVie | Ubrelvy | $137 | 18 payments
|
| Pfizer | Eliquis | $124 | 11 payments
|
| Amarin Pharma | Vascepa | $67 | 3 payments
|
| Sunovion Pharmaceuticals | Gemtesa | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $23 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $20 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $12 | 1 payment
|
2020: $509
| Novo Nordisk | Ozempic | $112 | 7 payments
|
| Teva Pharmaceuticals USA | Ajovy | $51 | 2 payments
|
| Arbor Pharmaceuticals | Edarbi | $48 | 2 payments
|
| Pfizer | Eucrisa | $43 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $43 | 2 payments
|
| Astellas Pharma US | Vesicare | $42 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $42 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $41 | 2 payments
|
| Lilly USA | Synjardy | $29 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $24 | 1 payment
|
| Seqirus USA | Flucelvax Quadrivalent (Multi-Dose Vial) | $19 | 1 payment
|
| AbbVie | Creon | $15 | 1 payment
|
2019: $1,944
| Teva Pharmaceuticals USA | Ajovy | $272 | 11 payments
|
| Pfizer | Eucrisa | $204 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $195 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $172 | 9 payments
|
| Allergan | Vraylar | $122 | 8 payments
|
| Mylan Specialty L.P. | Yupelri | $113 | 5 payments
|
| Lilly USA | Emgality | $101 | 6 payments
|
| Merck Sharp & Dohme | Pneumovax 23 | $97 | 6 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $92 | 10 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $89 | 5 payments
|
| AbbVie | Creon | $65 | 3 payments
|
| Amgen | Aimovig | $59 | 3 payments
|
| Arbor Pharmaceuticals | Edarbi | $59 | 3 payments
|
| Kowa Pharmaceuticals America | Livalo | $47 | 2 payments
|
| Genentech USA | Xofluza | $40 | 2 payments
|
| Philips Electronics North America | Reusable Vest | $40 | 1 payment
|
| GlaxoSmithKline | Shingrix | $33 | 2 payments
|
| Becton Dickinson and | Bd Surepath | $24 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $23 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $23 | 1 payment
|
| Amarin Pharma | Vascepa | $21 | 1 payment
|
| Bausch Health US | Aplenzin | $18 | 1 payment
|
| Seqirus USA | Fluad | $13 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $11 | 1 payment
|
| Sanofi Pasteur | No Product Discussed | $11 | 1 payment
|
Professional record
- NPI
- 1447358692
- Licence
- CA A90567California A90567: Current · expires 2027-01-31
- Group
- Bass Medical Group
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 221 E Hacienda Ave Ste B, Campbell, CA, 95008
- NPI first listed
- 2006-09-20
- NPI last updated
- 2025-02-11
- NPI record certified
- 2025-02-11
This is when the NPI record was last certified, not a medical board exam.